Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: ChemTrak

This article was originally published in The Gray Sheet

Executive Summary

ChemTrak: FDA requests more information regarding the firm's premarket approval application for the Aware home HIV test service. ChemTrak submitted the PMA in February 1995 ("The Gray Sheet" Feb. 20, 1995, In Brief). The company says it will respond to FDA's request "within the standard 180-day time frame set by the agency," noting that because of the "slower than previously anticipated development of the home HIV test market" it will focus more attention on "other opportunities which offer significantly greater short-term market potential"...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT008266

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel